Company News

  • 21 May 2019

    Flexipharm Austrading launches APML therapy in UK

    Flexipharm Austrading has launched the Arsenic Trioxide Phebra injection for the treatment of acute promyelocytic leukaemia (APML) after securing Medicines and Healthcare products Regulatory Agency (MHRA) marketing authorisation.

Go Top